News & Analysis on Clinical Trial Services & Contract Research And Development
Adcock Ingram recorded an 11 per cent rise in profit in the first half of 2010 and is looking to continue this upwards trend through manufacturing expansions, plus local and overseas acquisitions.
Videojet has partnered with Systech to help companies meet emerging regulations by introducing track and trace equipment to the Brazilian market.
Indian’s Biocon will supply US biopharma Optimer Pharmaceuticals with the API fidaxmicin for its candidate Clostridium difficile infection (CDI) drug OPT-80 under a new long-term contract.
India-based CRO Max Neeman has established central lab capabilities to support clinical trials, starting with a Phase II oncology study.
AMRI is reducing its US workforce 10 per cent and halting operations in one R&D lab at its facility in Rensselaer, New York as “softness” in the domestic market continues beyond its expectations.